Jocelyn Spoon is a Cardiology physician affiliated with The International Heart Institute of Montana. OpenAlex indexes 11 publications with 498 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
500 W Broadway St
Suite 320
Missoula, MT 598024008
Telephone
406-329-5615Provider last certified this registry record 6 Apr 2021.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20259 payments
- Edwards Lifesciences CorporationProgram year20251 payment
- Boston Scientific CorporationProgram year20246 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
67.2%Beta blocker22.5%Metoprolol Succinate59%Carvedilol29%Metoprolol Tartrate12%Part D<11 patientsStatin13.4%Atorvastatin Calcium70%Rosuvastatin Calcium30%Part D<11 patients+ 5 more classes in this area
Blood & clotting
29.8%P2Y12 inhibitor21.7%Clopidogrel100%Part D≥79 patientsFactor Xa inhibitor8.1%Eliquis64%Xarelto36%Part D<11 patientsMetabolism & gastrointestinal
2.9%Potassium supplement2.9%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure
JACC: Cardiovascular Interventions
2023 - Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion
Journal of the American College of Cardiology
2021 - Mechanisms of Mitral Valve Dysfunction Following Mitral Valve Repair for Degenerative Disease
JACC. Cardiovascular imaging
2015 - TWO DIMENSIONAL SPECKLE TRACKING ECHOCARDIOGRAPHY PREDICTS PRECLINICAL CARDIOTOXICITY IN BREAST CANCER PATIENTS
Journal of the American College of Cardiology
2014
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”